Ingmar Bruns: Biotech & Pharma Executive, Hematology & Oncology, Leadership

In this episode, our guest is Dr. Ingmar Bruns, M.D., Ph.D., a pioneer in biotech leadership and hematologist/oncologist. Dr Bruns is the Executive VP and CMO at Trillium Therapeutics Inc., a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We discuss Ingmar's breadth of experience in academia, where he studied medicine at both the Medical University of Vienna, as well as the Universität zu Lübeck, He then spent many years at both the University of Düsseldorf and the Albert Einstein College of Medicine.We discuss a variety of topics including Ingmar’s successes and mistakes, drug development, golden rules for biotechs, as well as fundraising in the life science industry. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentDr. Ingmar Bruns LinkedIn: https://www.linkedin.com/in/ingmar-bruns-9abb5446/Lawrence RoseCo-Founder + Talent Solutions Director At ARTOLinkedIn: https://www.linkedin.com/in/lawrencerose/Timestamps:00:00 Career Beginnings12:12 Key Accomplishments and Reflections20:50 Persistence in Drug Development27:52 Identifying Differentiators in Biotechs38:00 Communicating with Investors53:17 Traits of Effective Leadership#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Oncology #Hematology Hosted on Acast. See acast.com/privacy for more information.